合計 50 件の最近のインサイダー取引記録が記録されています KalVista Pharmaceuticals, Inc. (KALV), 内訳は 10 件の買い および 40 件の売り. インサイダー買い総額は RSU アワード インサイダー売り総額は $1.33M.
最近活動のある主要インサイダーには Venrock Healthcare Capital Partners Iii, L.p., Palleiko Benjamin L, Yea Christopher. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — KALV
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-03-26 |
Venrock Healthcare Capital Partners Iii, L.p. |
10 Percent Owner |
情報に基づく売り |
3,183 |
$19.12 |
$60.86K |
5,089,354 |
| 2026-03-25 |
Venrock Healthcare Capital Partners Iii, L.p. |
10 Percent Owner |
情報に基づく売り |
160 |
$17.53 |
$2.8K |
5,129,340 |
| 2026-03-09 |
Palleiko Benjamin L |
Chief Executive Officer |
情報に基づく売り |
6,693 |
$16.08 |
$107.63K |
451,815 |
| 2026-03-06 |
Palleiko Benjamin L |
Chief Executive Officer |
オプション行使（売却） |
15,625 |
- |
- |
125,001 |
| 2026-02-23 |
Palleiko Benjamin L |
Chief Executive Officer |
情報に基づく売り |
10,034 |
$15.57 |
$156.2K |
442,883 |
| 2026-02-23 |
Yea Christopher |
Chief Development Officer |
情報に基づく売り |
4,347 |
$15.57 |
$67.67K |
226,701 |
| 2026-02-23 |
Piekos Brian |
Chief Financial Officer |
情報に基づく売り |
1,767 |
$15.57 |
$27.51K |
13,762 |
| 2026-02-23 |
Sweeny Nicole |
Chief Commercial Officer |
情報に基づく売り |
3,975 |
$15.57 |
$61.88K |
47,003 |
| 2026-02-23 |
Audhya Paul K. |
Chief Medical Officer |
情報に基づく売り |
5,354 |
$15.57 |
$83.34K |
138,983 |
| 2026-02-22 |
Yea Christopher |
Chief Development Officer |
オプション行使（売却） |
3,125 |
- |
- |
28,125 |
| 2026-02-22 |
Sweeny Nicole |
Chief Commercial Officer |
オプション行使（売却） |
5,000 |
- |
- |
45,000 |
| 2026-02-22 |
Audhya Paul K. |
Chief Medical Officer |
オプション行使（売却） |
5,000 |
- |
- |
45,000 |
| 2026-02-21 |
Palleiko Benjamin L |
Chief Executive Officer |
オプション行使（売却） |
23,250 |
- |
- |
279,000 |
| 2026-02-21 |
Yea Christopher |
Chief Development Officer |
オプション行使（売却） |
3,750 |
- |
- |
45,000 |
| 2026-02-21 |
Piekos Brian |
Chief Financial Officer |
オプション行使 |
5,000 |
- |
- |
15,529 |
| 2026-02-21 |
Sweeny Nicole |
Chief Commercial Officer |
オプション行使 |
6,250 |
- |
- |
45,978 |
| 2026-02-21 |
Audhya Paul K. |
Chief Medical Officer |
オプション行使（売却） |
6,250 |
- |
- |
75,000 |
| 2026-02-18 |
Palleiko Benjamin L |
Chief Executive Officer |
情報に基づく売り |
1,038 |
$15.00 |
$15.57K |
429,667 |
| 2026-02-18 |
Yea Christopher |
Chief Development Officer |
情報に基づく売り |
1,109 |
$15.00 |
$16.64K |
224,173 |
| 2026-02-18 |
Audhya Paul K. |
Chief Medical Officer |
情報に基づく売り |
1,163 |
$15.00 |
$17.45K |
133,087 |
| 2026-02-17 |
Palleiko Benjamin L |
Chief Executive Officer |
オプション行使（売却） |
2,419 |
- |
- |
2,419 |
| 2026-02-17 |
Yea Christopher |
Chief Development Officer |
オプション行使（売却） |
1,774 |
- |
- |
1,774 |
| 2026-02-17 |
Audhya Paul K. |
Chief Medical Officer |
オプション行使（売却） |
2,419 |
- |
- |
2,419 |
| 2026-02-12 |
Palleiko Benjamin L |
Chief Executive Officer |
情報に基づく売り |
3,354 |
$15.70 |
$52.66K |
428,286 |
| 2026-02-11 |
Palleiko Benjamin L |
Chief Executive Officer |
オプション行使（売却） |
7,120 |
- |
- |
99,680 |
| 2026-01-16 |
Palleiko Benjamin L |
Chief Executive Officer |
RSU 付与（制限付株式） |
325,000 |
- |
- |
325,000 |
| 2026-01-16 |
Piekos Brian |
Chief Financial Officer |
RSU 付与（制限付株式） |
100,000 |
- |
- |
100,000 |
| 2026-01-16 |
Sweeny Nicole |
Chief Commercial Officer |
RSU 付与（制限付株式） |
100,000 |
- |
- |
100,000 |
| 2026-01-16 |
Audhya Paul K. |
Chief Medical Officer |
RSU 付与（制限付株式） |
100,000 |
- |
- |
100,000 |
| 2026-01-16 |
Arif Bilal |
Chief Operations Officer |
RSU 付与（制限付株式） |
49,000 |
- |
- |
49,000 |
| 2025-12-08 |
Palleiko Benjamin L |
Chief Executive Officer |
情報に基づく売り |
7,294 |
$16.51 |
$120.42K |
424,520 |
| 2025-12-06 |
Palleiko Benjamin L |
Chief Executive Officer |
オプション行使（売却） |
15,625 |
- |
- |
140,626 |
| 2025-11-24 |
Palleiko Benjamin L |
Chief Executive Officer |
情報に基づく売り |
10,940 |
$13.45 |
$147.15K |
416,189 |
| 2025-11-24 |
Yea Christopher |
Chief Development Officer |
情報に基づく売り |
4,331 |
$13.45 |
$58.26K |
223,508 |
| 2025-11-24 |
Piekos Brian |
Chief Financial Officer |
情報に基づく売り |
4,471 |
$13.45 |
$60.14K |
10,529 |
| 2025-11-24 |
Audhya Paul K. |
Chief Medical Officer |
情報に基づく売り |
5,296 |
$13.45 |
$71.24K |
131,831 |
| 2025-11-24 |
Sweeny Nicole |
Chief Commercial Officer |
情報に基づく売り |
3,813 |
$13.45 |
$51.29K |
39,728 |
| 2025-11-22 |
Yea Christopher |
Chief Development Officer |
オプション行使（売却） |
3,125 |
- |
- |
31,250 |
| 2025-11-22 |
Audhya Paul K. |
Chief Medical Officer |
オプション行使（売却） |
5,000 |
- |
- |
50,000 |
| 2025-11-22 |
Sweeny Nicole |
Chief Commercial Officer |
オプション行使 |
5,000 |
- |
- |
43,541 |
| 2025-11-21 |
Palleiko Benjamin L |
Chief Executive Officer |
オプション行使（売却） |
23,250 |
- |
- |
302,250 |
| 2025-11-21 |
Yea Christopher |
Chief Development Officer |
オプション行使（売却） |
3,750 |
- |
- |
48,750 |
| 2025-11-21 |
Piekos Brian |
Chief Financial Officer |
オプション行使 |
15,000 |
- |
- |
15,000 |
| 2025-11-21 |
Audhya Paul K. |
Chief Medical Officer |
オプション行使（売却） |
6,250 |
- |
- |
81,250 |
| 2025-11-21 |
Sweeny Nicole |
Chief Commercial Officer |
オプション行使 |
6,250 |
- |
- |
38,541 |
| 2025-11-20 |
Yea Christopher |
Chief Development Officer |
オプション行使（売却） |
87,390 |
$0.00 |
$375.78 |
- |
| 2025-11-18 |
Palleiko Benjamin L |
Chief Executive Officer |
情報に基づく売り |
4,466 |
$14.48 |
$64.67K |
403,879 |
| 2025-11-18 |
Yea Christopher |
Chief Development Officer |
情報に基づく売り |
2,683 |
$14.48 |
$38.85K |
133,574 |
| 2025-11-18 |
Audhya Paul K. |
Chief Medical Officer |
情報に基づく売り |
3,075 |
$14.48 |
$44.52K |
125,877 |
| 2025-11-17 |
Palleiko Benjamin L |
Chief Executive Officer |
オプション行使（売却） |
6,945 |
- |
- |
- |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
